Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells.

Science Translational Medicine
John SchollerCarl H June

Abstract

The success of adoptive T cell gene transfer for treatment of cancer and HIV is predicated on generating a response that is both durable and safe. We report long-term results from three clinical trials to evaluate gammaretroviral vector-engineered T cells for HIV. The vector encoded a chimeric antigen receptor (CAR) composed of CD4 linked to the CD3ζ signaling chain (CD4ζ). CAR T cells were detected in 98% of samples tested for at least 11 years after infusion at frequencies that exceeded average T cell levels after most vaccine approaches. The CD4ζ transgene retained expression and function. There was no evidence of vector-induced immortalization of cells; integration site distributions showed no evidence of persistent clonal expansion or enrichment for integration sites near genes implicated in growth control or transformation. The CD4ζ T cells had stable levels of engraftment, with decay half-lives that exceeded 16 years, in marked contrast to previous trials testing engineered T cells. These findings indicate that host immunosuppression before T cell transfer is not required to achieve long-term persistence of gene-modified T cells. Further, our results emphasize the safety of T cells modified by retroviral gene transfer in...Continue Reading

References

Oct 23, 1997·Proceedings of the National Academy of Sciences of the United States of America·O O YangB D Walker
Mar 14, 1998·Proceedings of the National Academy of Sciences of the United States of America·U RangaG J Nabel
Sep 6, 2001·Proceedings of the National Academy of Sciences of the United States of America·J H WangE L Reinherz
May 25, 2002·Molecular Therapy : the Journal of the American Society of Gene Therapy·Steven G DeeksKristen M Hege
Jan 4, 2003·Blood·Christopher BaumChristof von Kalle
Nov 11, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Shane CrottyRafi Ahmed
Mar 6, 2004·Proceedings of the National Academy of Sciences of the United States of America·Booki MinWilliam E Paul
Mar 4, 2006·Science·Jason HatayeMarc K Jenkins
May 2, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cor H J LamersEgbert Oosterwijk
May 12, 2006·Cell Cycle·Martin JanzStephan Mathas
Nov 9, 2006·Proceedings of the National Academy of Sciences of the United States of America·Bruce L LevineCarl H June
Dec 15, 2006·PLoS Computational Biology·Charles BerryFrederic D Bushman
Mar 12, 2008·Proceedings of the National Academy of Sciences of the United States of America·Sarah PalmerMartin S King
Apr 16, 2008·Nucleic Acids Research·Gary P WangFrederic D Bushman
Jun 21, 2008·Blood·Sebastian NewrzelaDorothee von Laer
Aug 9, 2008·The Journal of Clinical Investigation·Salima Hacein-Bey-AbinaMarina Cavazzana-Calvo
Nov 29, 2008·Methods : a Companion to Methods in Enzymology·Angela CiuffiFrederic D Bushman
Feb 14, 2009·The New England Journal of Medicine·Gero HütterEckhard Thiel
Mar 10, 2009·Genes & Development·Troy BradyFrederic D Bushman
Sep 17, 2010·Nature·Marina Cavazzana-CalvoPhilippe Leboulch
Mar 19, 2011·Nucleic Acids Research·Troy BradyFrederic D Bushman
May 13, 2011·Journal of Virology·Shoshannah L RothFrederic D Bushman

❮ Previous
Next ❯

Citations

Jul 13, 2013·Cell Death & Disease·A D BadleyS R Lewin
Jan 22, 2013·Human Gene Therapy·Alessia CavazzaFulvio Mavilio
Aug 14, 2013·Journal of Translational Medicine·Petra C SchuberthUlf Petrausch
Jul 9, 2013·Journal of Hematology & Oncology·Ethan Q HanShuang-yin Han
Apr 5, 2013·PloS One·Leonardo ChicaybamMartin Hernan Bonamino
Dec 26, 2013·Viruses·Anjie Zhen, Scott Kitchen
Jan 2, 2014·Viruses·Bryan P BurkeGero Hütter
Jun 20, 2014·PLoS Computational Biology·Borislav SavkovicJohn M Murray
Jan 16, 2014·Annual Review of Immunology·Marcela V MausCarl H June
Nov 28, 2013·Annual Review of Medicine·David M BarrettCarl H June
Apr 6, 2013·Immunotherapy·Sharon Lam, Catherine Bollard
Dec 18, 2013·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Hannah JethwaJohn Maher
Dec 17, 2014·Clinical & Translational Immunology·Michael H KershawPhillip K Darcy
Oct 10, 2013·EMBO Molecular Medicine·Kerstin B KaufmannManuel Grez
Jun 20, 2014·Cancer Immunology, Immunotherapy : CII·Carl H JuneDavid L Porter
Oct 29, 2014·Nature Reviews. Clinical Oncology·Crystal L MackallTerry J Fry
Apr 16, 2014·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ann M LeenJuan F Vera
Apr 24, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Tim HeinrichSebastian Newrzela
Dec 20, 2013·Viruses·Michael S Bennett, Ramesh Akkina
Jan 11, 2014·Cancer Immunology Research·Bridget P KeenanTodd D Armstrong
Apr 23, 2015·International Reviews of Immunology·Jose A FigueroaMaurizio Chiriva-Internati
Feb 15, 2016·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Hakan GokerYahya Buyukasik
May 8, 2015·Expert Opinion on Biological Therapy·Bruce LevineMegan Davis
Nov 23, 2013·Expert Opinion on Biological Therapy·Saar Gill, David L Porter
Apr 5, 2016·Seminars in Oncology·Joseph A FraiettaMarcela V Maus
Dec 15, 2015·Science Translational Medicine·Giacomo OliveiraChiara Bonini
Mar 19, 2014·Cytotherapy·Martin HildebrandtHelen E Heslop
Apr 9, 2013·Cytotherapy·J Joseph Melenhorst, Bruce L Levine
Apr 9, 2013·Hematology/oncology Clinics of North America·Marco L Davila, Renier Brentjens
Dec 19, 2012·Translational Research : the Journal of Laboratory and Clinical Medicine·Saar Gill, Michael Kalos
Jan 15, 2013·Translational Research : the Journal of Laboratory and Clinical Medicine·Perry B HackettLaurence J N Cooper
Jul 18, 2012·Cytotherapy·David L Digiusto, Hans-Peter Kiem
Jan 7, 2016·Nature Medicine·Christopher A KlebanoffNicholas P Restifo
Sep 13, 2015·Current Opinion in Pharmacology·Benjamin C HoughtonAdrian J Thrasher
Oct 21, 2015·Frontiers in Immunology·Mark A BrockmanZabrina L Brumme
Aug 29, 2012·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Michael C Milone, Lance C Kam
Mar 14, 2014·Internal Medicine Journal·J L Macpherson, J E J Rasko
Dec 18, 2013·Immunological Reviews·Marco Ruella, Michael Kalos
Dec 18, 2013·Immunological Reviews·Eric GschwengDonald B Kohn
Dec 18, 2013·Immunological Reviews·Robert H Vonderheide, Carl H June

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.